Osaic Holdings’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,686
| Closed | -$22.1K | – | 7598 |
|
|
2024
Q2 | $22.1K | Sell |
9,686
-739
| -7% | -$2.82K | ﹤0.01% | 5279 |
|
|
2024
Q1 | $45K | Sell |
10,425
-11,683
| -53% | -$40.7K | ﹤0.01% | 4824 |
|
|
2023
Q4 | $67.4K | Buy |
22,108
+3,026
| +16% | +$5.69K | ﹤0.01% | 4696 |
|
|
2023
Q3 | $27.5K | Buy |
19,082
+10,718
| +128% | +$20.7K | ﹤0.01% | 5378 |
|
|
2023
Q2 | $20.8K | Buy |
8,364
+3,571
| +75% | +$9.76K | ﹤0.01% | 5534 |
|
|
2023
Q1 | $12.8K | Buy |
4,793
+2,329
| +95% | +$11.2K | ﹤0.01% | 5825 |
|
|
2022
Q4 | $13K | Sell |
2,464
-5,963
| -71% | -$50K | ﹤0.01% | 5827 |
|
|
2022
Q3 | $105K | Buy |
8,427
+3,920
| +87% | +$44.8K | ﹤0.01% | 4330 |
|
|
2022
Q2 | $23K | Buy |
4,507
+3,599
| +396% | +$19.9K | ﹤0.01% | 5526 |
|
|
2022
Q1 | $193K | Buy |
908
+350
| +63% | +$3.32K | ﹤0.01% | 4062 |
|
|
2021
Q4 | $6K | Sell |
558
-1,078
| -66% | -$13.7K | ﹤0.01% | 6577 |
|
|
2021
Q3 | $21K | Sell |
1,636
-1,260
| -44% | -$20.5K | ﹤0.01% | 5750 |
|
|
2021
Q2 | $64K | Sell |
2,896
-7,506
| -72% | -$167K | ﹤0.01% | 4854 |
|
|
2021
Q1 | $250K | Buy |
10,402
+6,841
| +192% | +$159K | ﹤0.01% | 3546 |
|
|
2020
Q4 | $64K | Buy |
+3,561
| New | +$53.2K | ﹤0.01% | 4391 |
|
|
2020
Q3 | – | Sell |
-650
| Closed | -$15K | – | 6465 |
|
|
2020
Q2 | $15K | Sell |
650
-3,054
| -82% | -$50.5K | ﹤0.01% | 4982 |
|
|
2020
Q1 | $41K | Buy |
+3,704
| New | +$69.2K | ﹤0.01% | 4134 |
|
Osaic Holdings's GTHX Position: Q3 2024 in Review
Osaic Holdings sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 9,686 shares — an estimated $22.1K sold.
Osaic Holdings first reported a position in GTHX in Q1 2020 and held it in 17 quarters. The position peaked at $250K in Q1 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- Osaic Holdings reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Osaic Holdings sold 9,686 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $22.1K.
- Osaic Holdings first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2020 and held it in 17 quarters.
- Osaic Holdings's G1 Therapeutics, Inc. Common Stock position peaked at $250K in Q1 2021.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.
Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.